METV VS HSCS Stock Comparison
Performance
METV100/100
100/100
METV returned 34.13% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.
HSCS10/100
10/100
HSCS returned -91.48% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Technicals
METV86/100
86/100
METV receives a 85 of 100 based on 14 indicators. 12 are bullish, 2 are bearish.
HSCS11/100
11/100
HSCS receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.
Volatility
METV52/100
52/100
METV has had a higher than average amount of volatility over the last 12 months giving it a score of 52 of 100.
HSCS38/100
38/100
HSCS has had a lower than average amount of volatility over the last 12 months giving it a score of 38 of 100.
Earnings
METV
"Earnings" not found for METV
HSCS100/100
100/100
HSCS has missed earnings 1 times in the last 20 quarters.
Profit
METV
"Profit" not found for METV
HSCS10/100
10/100
Out of the last 10 quarters, HSCS has had 0 profitable quarters and has increased their profits year over year on 0 of them.
All score calculations are broken down here to help you make more informed investing decisions
Roundhill Ball Metaverse ETF Summary
Financial Services
Asset Management
The index seeks to track the performance of globally-listed equity securities of companies that engage in activities or provide products, services, technologies, or technological capabilities to enable the Metaverse, and benefit from its generated revenues. "Metaverse" is a term used to refer to a future iteration of the Internet. Under normal circumstances, at least 80% of the fund's net assets will be invested in Metaverse Companies, which may include investments in ADRs or SPACs. The fund is non-diversified.
Heart Test Laboratories, Inc. Common Stock Summary
Nasdaq / HSCS
Healthcare
Medical - Devices
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare METV to other companies in the same or a similar industry.
